Modulation of mTORC1 has proven beneficial in experimental spinal cord injury, making this molecular target a candidate for therapeutic intervention in spinal cord injury.
The genomic abundance of microsatellites, and their ability to associate with many phenotypes, make this class of molecular markers a powerful tool for diverse application in plant genetics.
While in the future it may be possible to make this distinction by molecular analysis of the tumor [ 20], at present the most plausible explanation for the overwhelming majority of cases of multifocal myxoid liposarcoma is metastatic disease [ 9].
So what do the researchers make of this molecular milieu?
Finally, the 1b up-regulation of p21 expression and apoptosis induction seem to be the mechanisms by which it promotes its anti-leukemic effects, making this new molecular architecture a promising prototype for leukemia intervention.
These results support the conclusion that the PTC transcriptome differs from the normal one in thousands of genes; they also provide evidence that optimizing a diagnostic gene set is a necessary step of analysis in order to make this set useful for molecular PTC classification.
To make this scenario fulfilled, elucidations of molecular pathogenesis in different subtypes of CRC are crucial.
And finally, we cannot exclude a technical failure of the methods, although the consistency of the findings and the broad experience of the investigators with molecular techniques make this possibility unlikely [ 37- 40].
Unfortunately, the underlying molecular dynamics simulations make this protocol quite time-consuming.
Although it is possible to use biological polymers to do this, molecular machines made from DNA are obviously far more limited in terms of operating conditions, chemical stability, and functionality than wholly synthetic systems.
